SEC Form D private-offering filing

SLAM BioTherapeutics, Inc.

A new SEC Form D private-offering notice from Westlake Village, CA, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.

SLAM BioTherapeutics, Inc. site↗ Verified via SEC Form D

Oncology biotech developing first in class antibody drug conjugates and bispecific antibodies targeting SLAMF5 for blood cancers including MDS, AML, CTCL, and follicular lymphoma.

Filed 2025-12-29Filed to raise $4,000,000First money in 2025-12-19Raised so far $1,000,000HQ (as filed) Westlake Village, CASector Biotech Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified slambio.com↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.